394 results on '"Housset C"'
Search Results
2. L’encéphalopathie hépatique, du diagnostic au traitement en 2016
3. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
4. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia
5. Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells
6. Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins
7. Morphological and Biochemical Integrity of Human Liver Slices in Long-Term Culture: Effects of Oxygen Tension
8. Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium
9. Involvement of hepatic stellate cell-derived myofibroblasts and portal myofibroblasts in liver fibrosis: A comparative study using proteomics and transcriptomics: C3.06
10. Sodium benzoate and rifaximin are able to restore blood-brain barrier integrity in he cirrhotic rats
11. AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)
12. Cytotoxic response of sinusoidal endothelial cells to polymorphonuclear leukocytes and its potential implication in hypoxia-reoxygenation injury
13. Direct cytotoxicity of hypoxia-reoxygenation towards sinusoidal endothelial cells in the rat
14. Magnetic resonance risk score and liver stiffness by transient elastography have complementary prognostic values in patients with Primary Sclerosing Cholangitis
15. Two simple magnetic resonance scores are able to predict survival in patients with Primary Sclerosing Cholangitis
16. GS6/34 REGULATORY ROLE OF ENDOTHELIN-1 ON ION TRANSPORT IN THE HUMAN GALLBLADDER EPITHELIUM
17. Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study
18. Two new blood tests for identifying patients with chronic liver diseases, at high risk of primary liver cancer
19. An effective defatting cocktail to reduce liver graft steatosis before transplantation
20. Long term prognostic value of the FibroTest in patients with non-alcoholic-fatty-liver disease (NAFLD), compared to chronic hepatitis C (CHC), B (CHB), and alcoholic liver disease (ALD)
21. Refinement of diagnostic criteria and frequency estimation of LPAC syndrome: A French multicenter study
22. During the progression of liver fibrosis, myofibroblasts develop endoplasmic reticulum stress that both decreases their proliferation and increases their pro-angiogenic activity
23. Impact of NASH, gender, fasting glucose and body mass index on the liver fibrosis transition rate (FTR) in metabolic liver disease (MLD)
24. Illuminating liver fibrosis with vitamin D
25. Proffered Paper: Mechanical induction of the tumourogenic beta-catenin pathway by tumour growth pressure
26. Fibroscan and MRI Have Complementary Prognostic Values in Primary Sclerosing Cholangitis
27. Fibroscan Improves the Ability of the New Prognostic Scoring Systems to Predict Outcomes of Pbc
28. Serum Bile Acid Profiles are Associated with Histological Severity in Patients with Non-Alcoholic Fatty Liver Disease
29. Development an in Vitro Model Culture for Testing of Anti-Fibrotic Drugs using Human Precision Cut Liver Slices
30. Spectrum of NAFLD Severity in a Large Population using Software-Combined Tests of Steatosis, Necroinflammatory Activity, and Fibrosis (Fibromax) in Comparison with Patients with Chronic Hepatitis C
31. Changes in Nuclear Receptor Expression Induced by Cholestasis in Mouse Liver Cells
32. SAT-111 - An effective defatting cocktail to reduce liver graft steatosis before transplantation
33. SAT-031 - Refinement of diagnostic criteria and frequency estimation of LPAC syndrome: A French multicenter study
34. FRI-128 - Two new blood tests for identifying patients with chronic liver diseases, at high risk of primary liver cancer
35. FRI-088 - During the progression of liver fibrosis, myofibroblasts develop endoplasmic reticulum stress that both decreases their proliferation and increases their pro-angiogenic activity
36. PS-183 - Long term prognostic value of the FibroTest in patients with non-alcoholic-fatty-liver disease (NAFLD), compared to chronic hepatitis C (CHC), B (CHB), and alcoholic liver disease (ALD)
37. P0083 : Sodium benzoate and rifaximin are able to restore blood-brain barrier integrity in cirrhotic rats with hepatic encephalopathy
38. P1175 : Ability of a simple radiologic score, assessed by three-dimensional Magnetic Resonance Cholangiography (MRC), to predict clinical outcome of patients with Primary Sclerosing Cholangitis (PSC)
39. Mélatonine dans la sédation de l’enfant avant électroencéphalogramme : quelle posologie ?
40. P400 PHOSPHORYLATION OF ABCB4 IS NECESSARY FOR PHOSPHATIDYLCHOLINE SECRETION: INSIGHTS FROM DISEASE-CAUSING VARIANTS
41. P327 PROFILING NEW BIOMARKERS FOR THE DIAGNOSIS OF DRUG INDUCED LIVER NECROSIS. A PILOT STUDY ASSESSING PERFORMANCE OF CLEAVED OR FULL-LENGTH CYTOKERATIN 18, AND MICRO-RNA-122
42. P1268 IMPACT OF DIET ON GUT MICROBIOTA AND LIVER PHENOTYPE IN CFTR KNOCKOUT MICE
43. P48 EGF/EGFR AXIS CONTRIBUTES TO THE PROGRESSION OF CHOLANGIOCARCINOMA THROUGH THE INDUCTION OF AN EPITHELIAL–MESENCHYMAL TRANSITION
44. P1024 PRESENCE OF HEPATIC STEATOSIS AS PER NON-INVASIVE BIOMARKERS OVERESTIMATES FIBROSIS STAGES BASED ON LIVER STIFFNESS MEASUREMENT (LSM) BY TRANSIENT ELASTOGRAPHY IN TYPE-2 DIABETIC (T2D) PATIENTS
45. P118 P2×4 IMPACTS BILIARY HOMEOSTASIS AND INFLAMMATORY RESPONSE AFTER PARTIAL HEPATECTOMY IN MICE
46. SAT-486 - Spectrum of NAFLD Severity in a Large Population using Software-Combined Tests of Steatosis, Necroinflammatory Activity, and Fibrosis (Fibromax) in Comparison with Patients with Chronic Hepatitis C
47. SAT-413 - Development an in Vitro Model Culture for Testing of Anti-Fibrotic Drugs using Human Precision Cut Liver Slices
48. SAT-378 - Changes in Nuclear Receptor Expression Induced by Cholestasis in Mouse Liver Cells
49. FRI-329 - Serum Bile Acid Profiles are Associated with Histological Severity in Patients with Non-Alcoholic Fatty Liver Disease
50. PS086 - Fibroscan Improves the Ability of the New Prognostic Scoring Systems to Predict Outcomes of Pbc
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.